Trending...
- Street Smart, Future Ready Audible Edition Soars to #1 New Release on Audible!
- MLM Unlimited Enterprise, LLC Announces DBE Certification
- 2025 HFM Symposium - Optimizing the Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure
This CME Symposium takes place on Thursday, June 12, 2025, from 11:15 AM - 12:15 PM ET during the AAHFN Annual Meeting at the Savannah Convention Center in Savannah, Georgia.
HAZLET, N.J. - JerseyDesk -- Despite strong evidence for cardiorenal protective effects of RAASis, hyperkalemia (or fear of hyperkalemia) is a major driver of underuse and underdosing of RAASis in HF; these actions place HF patients at increased risk since dose reduction or discontinuation of RAASis is associated with worse outcomes in HF. Novel potassium binders effectively and safely lower serum potassium, potentially facilitating optimization of the use and dosing of RAASis. This symposium will include recent clinical evidence with potassium binders and a case discussion of roles and best practices of HF Nurses in managing hyperkalemia in their HF patients.
Click here for more information
CHAIR
Marie Galvao, MSN, ANP-BC, CHFN, HF-Cert
More on Jersey Desk
Lead Heart Failure Nurse Practitioner
Center for Advanced Cardiac Therapy
Montefiore Medical Center
Bronx, New York
FACULTY
Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina
Lisa Rathman, MSN, CRNP, ACNP-BC, CHFN
Lead Nurse Practitioner
Heart Failure Section
Penn Medicine Lancaster General Health
Lancaster, Pennsylvania
Educational Objectives
- Explain the relationship between down-titration or discontinuation of RAASi therapy and clinical outcomes
- Interpret evidence from clinical trials of novel potassium binders for the treatment of hyperkalemia
- Identify HF patients who would benefit from potassium-lowering pharmacological therapy
Target Audience
This educational activity is intended for Heart Failure Nurses.
Educational Grant
AAHFN and Voxmedia International gratefully acknowledge the educational grant provided by AstraZeneca Pharmaceuticals.
Continuing Education Credits
AAHFN and Voxmedia International gratefully acknowledge the educational grant provided by AstraZeneca Pharmaceuticals.
Click here for more information
CHAIR
Marie Galvao, MSN, ANP-BC, CHFN, HF-Cert
More on Jersey Desk
- United States Congressional Candidate Peter Coe Verbica Unveils 25-Point Federal Plan to Help Make California Affordable Again
- D8Averse Launches D8Acapture: Disruptive Mobile-First App Transforms Utility Pole Data Collection
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator
- Mauro Schnaidman named as Managing Director in Miami, Florida
- Corner Property Management Appointed Managing Agent for Minneakoning Business Center in Flemington
Lead Heart Failure Nurse Practitioner
Center for Advanced Cardiac Therapy
Montefiore Medical Center
Bronx, New York
FACULTY
Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina
Lisa Rathman, MSN, CRNP, ACNP-BC, CHFN
Lead Nurse Practitioner
Heart Failure Section
Penn Medicine Lancaster General Health
Lancaster, Pennsylvania
Educational Objectives
- Explain the relationship between down-titration or discontinuation of RAASi therapy and clinical outcomes
- Interpret evidence from clinical trials of novel potassium binders for the treatment of hyperkalemia
- Identify HF patients who would benefit from potassium-lowering pharmacological therapy
Target Audience
This educational activity is intended for Heart Failure Nurses.
Educational Grant
AAHFN and Voxmedia International gratefully acknowledge the educational grant provided by AstraZeneca Pharmaceuticals.
Continuing Education Credits
AAHFN and Voxmedia International gratefully acknowledge the educational grant provided by AstraZeneca Pharmaceuticals.
Source: CMEPlanet
0 Comments
Latest on Jersey Desk
- Robert Michael & Co. Launches New Real Estate Website to Serve Central Florida Homebuyers and Sellers
- IFFA 2025 Shines Bright as Mukesh Modi Welcomes Rio Rocket and Award Winner Lulu Lopez
- Kemeny, Ramp & Renaud Expands Legal Team with Attorney Baruch Kraut
- Cohort 2 Graduates Are Ready to Lead: East Orange Entrepreneurs Step Forward With Power & Purpose
- WOA Entertainment Group Unveils Independent No.1's: Breakthrough Artists II —A Celebration of Indie Excellence
- SheepFeast Launches "1 Million Discipled" Global Initiative to Empower Disciple-Making Around the World
- Sun City Resident Realtor Launches Exclusive Weekly Market Update for Bluffton's 55+ Communities!
- Delta Capital Group, Inc. Earns A+ Rating from the Better Business Bureau, Marking Another Milestone in Explosive Growth
- Vice President JD Vance & Industry Leaders at Bitcoin Conference After Partnership Signing to Optimize Cybersecurity Solutions: Bullet Blockchain, Inc
- Congratulations Class of 2025! Southern Ocean Chamber Scholarships
- Actress/Comedian Schelle Purcell Sizzles This Summer with Star-Making Turn in Tyler Perry's #1 Netflix Film, Straw, and Upcoming Comedy Special
- Braxus Entertainment Group Acquires All Star Events
- Global Expansion Fueled via Agreement to Take 90% Ownership of Nook Holdings UAE-Based Sports Incubator by Online Lottery & Sports Game Provider
- Remember Internet Pioneers NetCom Solutions & Network Solutions? Founder Emmit J. McHenry is Now Leading the Emerging Cybersecurity Firm Cycurion
- Axtria Ignite 2025: Defining Leadership in the Agentic AI Era for the Life Sciences Industry
- Celebrating Father's Day Weekend with Free Admission for the entire Family, AKC Dog Show, Best in Show and Puppy Event, Product Vendors
- LIB Continuous Innovation: Custom Rain Test Chambers & IP Labs
- csky.ai & DuoKey Launch Secure AI Transcription Solution for Microsoft 365
- PlayClay.io Launches Streamlined Quoting Platform for Manufacturers' Reps and Distributors
- Corner Property Management Now Managing Van Wagenen Terrace COA in Jersey City, NJ